URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat HER2 cancers: drug shows promise in real-world study
Disease control Recruiting nowThis study looks at how well the drug T-DXd works in adults with advanced HER2-positive solid tumors that have spread and are not responding to other treatments. About 100 people will be followed to see if their tumors shrink and how long that lasts. The goal is to provide a trea…
Matched conditions: URETHRAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
New PET tracer could reveal which cancers will respond to immunotherapy
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 64Cu-GRIP B that lights up immune activity in PET scans. It aims to see if the tracer is safe and can help detect which advanced cancers (like prostate, kidney, or bladder) are more likely to respond to immunotherapy. About 91 adul…
Matched conditions: URETHRAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated May 01, 2026 15:57 UTC
-
Massive cancer registry aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is creating a large database of medical information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. The goal is to help researchers better understand what causes cancer, how it progresses, and how to improve p…
Matched conditions: URETHRAL CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC